Phase-I/II radio-immunotherapy study with Iodine-131-labeled anti-CEA monoclonal antibody F6 F(ab')2 in patients with non-resectable liver metastases from colorectal cancer.

Experimental studies in nude mice with human colon-carcinoma grafts demonstrated the therapeutic efficiency of F(ab')2 fragments to carcinoembryonic antigen (CEA) labeled with a high dose of 131Iodine. A phase I/II study was designed to determine the maximum tolerated dose of 131I-labeled F(ab')2 fragments (131I-F(ab')2) from anti-CEA monoclonal antibody F6, its limiting organ toxicity and tumor uptake. Ten patients with non-resectable liver metastases from colorectal cancer (9 detected by CT scan and 1 by laparotomy) were treated with 131I-F(ab')2, doses ranging from 87 mCi to 300 mCi for the first 5 patients, with a constant 300-mCi dose for the last 5 patients. For all the patients, autologous bone marrow was harvested and stored before treatment. Circulating CEA ranged from 2 to 126 ng/ml. No severe adverse events were observed during or immediately following infusion of therapeutic doses. The 9 patients with radiologic evidence of liver metastases showed uptake of 131I-F(ab')2 in the metastases, as observed by single-photon-emission tomography. The only toxicity was hematologic, and no severe aplasia was observed when up to 250 mCi was infused. At the 300-mCi dose, 5 out of 6 patients presented grade-3 or -4 hematologic toxicity, with a nadir for neutrophils and thrombocytes ranging from 25 to 35 days after infusion. In these 5 cases, bone marrow was re-infused. No clinical complications were observed during aplasia. The tumor response could be evaluated in 9 out of 10 patients. One patient showed a partial response of one small liver metastasis (2 cm in diameter) and a stable evolution of the other metastases, 2 patients had stable disease, and 6 showed tumor progression at the time of evaluation (2 or 3 months after injection) by CT scan. This phase-I/II study demonstrated that a dose of 300 mCi of 131I-F(ab')2 from the anti-CEA Mab F6 is well tolerated with bone-marrow rescue, whereas a dose of 200 mCi can be infused without severe bone-marrow toxicity.

Loss of single HLA class I allospecificities in melanoma cells due to selective genomic abbreviations.

Expression of human leucocyte antigen (HLA) Class I molecules is essential for the recognition of malignant melanoma (MM) cells by CD8(+) T lymphocytes. A complete or partial loss of HLA Class I molecules is a potent strategy for MM cells to escape from immunosurveillance. In 2 out of 55 melanoma cell cultures we identified a complete phenotypic loss of HLA allospecificities. Both patients have been treated unsuccessfully with HLA-A2 peptides. To identify the reasons underlying the loss of single HLA-A allospecificities, we searched for genomic alterations at the locus for HLA Class I alpha-chain on chromosome 6 in melanoma cell cultures established from 2 selected patients with MM in advanced stage. This deficiency was associated with alterations of HLA-A2 gene sequences as determined by polymerase chain reaction-sequence specific primers (PCR-SSP). Karyotyping revealed a chromosomal loss in Patient 1, whereas melanoma cell cultures established from Patient 2 displayed 2 copies of chromosome 6. Loss of heterozygosity (LOH) using markers located around position 6p21 was detected in both cases. By applying group-specific primer-mixes spanning the 5'-flanking region of the HLA-A2 gene locus the relevant region was amplified by PCR and subsequent sequencing allowed alignment with the known HLA Class I reference sequences. Functional assays using HLA-A2-restricted cytotoxic T-cell clones were performed in HLA-A2 deficient MM cultures and revealed a drastically reduced susceptibility to CTL lysis in HLA-A2 negative cells. We could document the occurrence of selective HLA-A2 deficiencies in cultured advanced-stage melanoma metastases and identify their molecular causes as genomic alterations within the HLA-A gene locus.

Argon@uta : Les TIC a les webs dels museus d'història i arqueologia

En un principi, aquest projecte es va concebre com un treball de recerca aplicada sobre les possibilitats que obrien les TIC en la gestió del patrimoni. Per tant, es volien contemplar tots els àmbits que conformen la gestió patrimonial: la difusió, la conservació, la gestió d'equipaments, la restauració, la investigació... El resultat d'aquest treball es volia plasmar en la creació d'una pàgina de recursos virtuals per a la gestió del patrimoni que contemplaria dues vessants. D'una banda, aplegaria un recull d'experiències en l'àmbit virtual d'arreu del món -CD's, planes web, interactius...- que poguessin servir de referent als professionals de la gestió patrimonial i als estudiants d'aquest àmbit. D'altre banda, aquesta plana volia oferir una anàlisi crítica i comentari dels recursos seleccionats.

Biblioteques : de Gutenberg a l'e-book. Estudi de tres biblioteques de la ciutat de Barcelona: Biblioteca de Sant Pau i Santa Creu, Biblioteca de la Universitat Pompeu Fabra i Biblioteca de la Universitat Oberta de Catalunya

Les biblioteques han deixat de ser simples dipòsits de llibres per complir funcions molt diverses en la societat actual. L'objectiu d'aquest treball no és fer un repàs històric sinó centrar-nos en la situació actual fortament influenciada per les noves tecnologies, les noves necessitats dels usuaris i altres factors com són el nou paradigma docent, la multiculturalitat, la situació econòmica, els fluxos migratoris, etc. Veurem els canvis que aquestes institucions han hagut d'adoptar, tant a nivell de personal, com d'instal·lacions i recursos, per adequar-se a aquesta nova realitat.

Com es recorre en les noves formes d'organització de treball (NFOT) a la subjectivitat del treballador i quines repercussions té en el procés de treball en LED?

Anàlisi de la introducció de les noves formes de treball a una empresa que introdueix tot un canvi de cultura per adaptar-se a la realitat empresarial i com afecta això em la subjectivitat dels treballadors.

Implantación de una solución SIG para la ayuda a la toma dedecisiones para la explotación de recursos del subsuelo

L'objectiu és una aplicació que permeti realitzar el càlcul del volum de terres disponibles en el subsòl d'un àrea seleccionada. L'objectiu final del projecte serà crear un Sistema d'Informació Geogràfica SIG que ajudi a valorar quines parcel¿les de l'àrea seleccionada són les que disposen de més volum de terres per iniciar la seva explotació. Per a això, es disposa del programari gvSIG i les seves extensions (SEXTANTE) i de tota la informació que es pugui obtenir sobre els SIG, Cartografia, Geodèsia... Per dur a terme aquest projecte es necessita tenir experiència en Bases de dades, Programació Orientada a Objectes i seria recomanable tenir coneixements sobre Enginyeria del Programador. El projecte se centrarà en la utilització de gvSIG, com un exemple concret de programari SIG de lliure accés, solució desenvolupada per la ¿Conselleria d%o2019Obris Publiquis de la Generalitat Valenciana¿. Una part d'aquest projecte consistirà a avaluar aquest programari. El resultat final serà l'obtenció dels coneixements necessaris per poder treballar amb dades espacials a més d'una aplicació SIG per al càlcul del volum de terres d'un àrea seleccionada.

Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925).

INTRODUCTION: The EORTC 22922/10925 trial investigated the potential survival benefit and toxicity of elective irradiation of the internal mammary and medial supraclavicular (IM-MS) nodes Accrual completed in January 2004 and first results are expected in 2012. We present the toxicity reported until year 3 after treatment. PATIENTS AND METHODS: At each visit, toxicity was reported but severity was not graded routinely. Toxicity rates and performance status (PS) changes at three years were compared by chi(2) tests and logistic regression models in all the 3,866 of 4,004 patients eligible to the trial who received the allocated treatment. RESULTS: Only lung (fibrosis; dyspnoea; pneumonitis; any lung toxicities) (4.3% vs. 1.3%; p < 0.0001) but not cardiac toxicity (0.3% vs. 0.4%; p = 0.55) significantly increased with IM-MS treatment. No significant worsening of the PS was observed (p = 0.79), suggesting that treatment-related toxicity does not impair patient's daily activities. CONCLUSIONS: IM-MS irradiation seems well tolerated and does not significantly impair WHO PS at three years. A follow-up period of at least 10 years is needed to determine whether cardiac toxicity is increased after radiotherapy.

Implantanció d'un sistema ERP SAP R/3 en una administració educativa

Aquest treball aprofundeix en el Departament d'Educació com a gran empresa, n'analitza els objectius, les funcions i l'estructura organitzativa i estudia els avantatges que podria aportar la implantació d'un ERP. També estudia amb detall els passos que s'haurien de seguir per a implantar SAP R/3 i n'assenyala els punts febles per tal de prevenir-los i assegurar l'èxit de la implantació.

Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.

BACKGROUND: Pharmacological interruption of the renin-angiotensin system focuses on optimization of blockade. As a measure of intrarenal renin activity, we have examined renal plasma flow (RPF) responses in a standardized protocol. Compared with responses with angiotensin-converting enzyme inhibition (rise in RPF approximately 95 mL x min(-1) x 1.73 m(-2)), greater renal vasodilation with angiotensin receptor blockers (approximately 145 mL x min(-1) x 1.73 m(-2)) suggested more effective blockade. We predicted that blockade with the direct oral renin inhibitor aliskiren would produce renal vascular responses exceeding those induced by angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. METHODS AND RESULTS: Twenty healthy normotensive subjects were studied on a low-sodium (10 mmol/d) diet, receiving separate escalating doses of aliskiren. Six additional subjects received captopril 25 mg as a low-sodium comparison and also received aliskiren on a high-sodium (200 mmol/d) diet. RPF was measured by clearance of para-aminohippurate. Aliskiren induced a remarkable dose-related renal vasodilation in low-sodium balance. The RPF response was maximal at the 600-mg dose (197+/-27 mL x min(-1) x 1.73 m(-2)) and exceeded responses to captopril (92+/-20 mL x min(-1) x 1.73 m(-2); P<0.01). Furthermore, significant residual vasodilation was observed 48 hours after each dose (P<0.01). The RPF response on a high-sodium diet was also higher than expected (47+/-17 mL x min(-1) x 1.73 m(-2)). Plasma renin activity and angiotensin levels were reduced in a dose-related manner. As another functional index of the effect of aliskiren, we found significant natriuresis on both diets. CONCLUSIONS: Renal vasodilation in healthy people with the potent renin inhibitor aliskiren exceeded responses seen previously with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. The effects were longer lasting and were associated with significant natriuresis. These results indicate that aliskiren may provide more complete and thus more effective blockade of the renin-angiotensin system.

Insulinoma associated with a case of multiple endocrine neoplasia type I: Functional somatostatin receptors and abnormal glucose-induced insulin secretion.

A sporadic case of multiple endocrine neoplasia type I with coexisting insulinoma and hyperparathyroidism was investigated in vivo and in vitro. The insulinoma was localized by somatostatin receptor scintigraphy and these receptors were functionally active. Octreotide administration decreased the basal insulin and glucagon secretion by 90 and 46%, respectively. Immunocytochemistry of the insulinoma tissue was positive for insulin, chromogranin A and neuropeptide Y. The insulinoma cells were also isolated and cultured in vitro. Incubation experiments revealed that a low glucose concentration (1 mmol/l) was sufficient to increase cytosolic free calcium and to produce a maximal glucose-induced insulin release. Northern blot analysis of RNA obtained from the tumor showed a high abundance of the low Km glucose transporter GLUT1 but no transcript for the high Km glucose transporter GLUT2. The abnormal distribution of glucose transporters probably relates to the abnormal glucose sensing of insulinoma cells, and explains their sustained insulin secretion at low glucose concentrations. Whether these abnormalities share a pathogenetic link with the presence of functionally active somatostatin receptors remains to be elucidated.

Construcció i explotaciód'un magatzem de dades per a l'anàlisid'informació immobiliària

Per encàrrec d'una empresa immobiliària s'ha construït un magatzem de dades a partir d'un fitxer en format text amb els registres de 92.555 immobles amb la finalitat de, mitjançant consultes sobre aquestes dades utilitzant eines OLAP, obtenir informació sobre el mercatimmobiliari.

Manteniment i seguiment de les ofertes públiques d'ocupació

L'objectiu de l'aplicació és el de facilitar al departament de personal el manteniment a la web del llistat de les ofertes d'ocupació, i informatitzar aquest procediment que fins ara es feia de maneramanual editant manualment fitxers html.

Disseny i implementació d'un sistema de gestió intel·ligent per una biblioteca

El projecte consisteix a crear una base de dades per a una biblioteca, que gestioni de forma òptima i intel·ligent els préstecs dels seus recursos. Per a això s'utilitza la base de dades Oracle, utilitzant SQL i PL/SQL i dissenyarem l'esmentada base de dades de manera que no estigui tancada per a una única interfície, i que s'incloguin totes les informacions requerides i preparades per a possibles canvis en un futur